(Q38300574)

1 September 2017

title

Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B. (English)

1 reference

1 September 2017

0 references

1 reference

1 reference

Rowland TL

1

1 reference

1 September 2017

McHugh SM

2

1 reference

1 September 2017

Deighton J

3

1 reference

1 September 2017

Ewan PW

4

1 reference

1 September 2017

Dearman RJ

5

1 reference

1 September 2017

Kimber I

6

1 reference

1 September 2017

publication date

1 January 2001

1 reference

International Immunopharmacology

1 September 2017

published in

1 reference

1 September 2017

volume

1

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

49-61

1 reference

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

The role of nuclear factor-kappa B in cytokine gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

A review of the drug treatment of cachexia associated with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Thalidomide inhibits the replication of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Synthesis of 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and novel derivatives free of positional isomers. Potent inhibitors of cAMP-specific phosphodiesterase and of malignant tumor cell growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2800%2900265-4

7 January 2021

10.1016/S0162-3109(00)00265-4

Identifiers

DOI

1 reference

1 September 2017

1 reference